Review Article

Medical Therapy of Acromegaly

Table 3

Comparison of primary versus secondary medical therapy (mTx).

MedicationDoseRemission (% of pats)Criteria for remissionAuthor
GHIGF-1GHIGF-1

Prim. mTx26Octr. s.c.777  g/d (mean)4368<2  g/L Normal** Newman et al. 1998 [135]
Sec. mTx81635  g/d (mean)2262

Prim. mTx23Lanr. SR30 mg/10–14 d6451basal GH
< 7.5 U/L
Normal* Baldelli et al. 2000 [136]
Sec. mTx717870

Prim. mTx15Octr. LAR10–40 mg/mo7353<2.5  g/L or <1  g/L (oGTT) Normal* Colao et al. 2001 [119]
Sec. mTx217671

Prim. mTx10Octr. LAR or Lanr. SR20 mg/6 w–30 mg/4 w5060<2  g/L Normal* Ayuk et al. 2002 [134]
Sec. + prim. mTx2230 mg/2 w–30 mg/10 d3662

IGF-1 concentration, age adjusted; IGF-1 concentration, not age adjusted.